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ANGIOGENESIS INHIBITION HAS THE POTENTIAL TO REDUCE PAIN IN THE
RAT MENISCAL INJURY MODEL OF OSTEOARTHRITIS
S. Ashraf, P.I. Mapp, D.A. Walsh
Arthritis Res. UK Pain Ctr., Academic Rheumatology, Univ. of Nottingham,
Nottingham, United Kingdom
Purpose: The rat meniscal injury (MNX) model of osteoarthritis (OA)
resembles changes observed in human tibiofemoral OA such as cartilage
damage,osteophyte formation and angiogenesis,both in the synovium and
at the osteochondral junction.With its mild to moderate severity and a time
course of 5 weeks it provides a suitable disease model to explore factors
that may either exacerbate or relieve OA.The angiogenesis inhibitor PPI-
2458 is an irreversible inhibitor of the enzyme methionine aminopeptidase
(MetAP)-2.It exerts its anti-angiogenic potential by arresting endothelial
cells in the G1 phase of the cell cycle thereby inhibiting their prolif-
eration.We set out to determine whether angiogenesis inhibition using
PPI-2458 reduces pain and osteoarthritic structural changes in the MNX
model of OA.
Methods: OA pathology was induced by transecting the meniscus in male
Lewis rats (n = 8 per group,weight = 300g) on day 0.Treatment with
PPI-2458 (5mg/kg,orally,every other day) or vehicle control was given
from day 11 to 34.Naïve animals were used as the baseline controls.On
day 35,synovia were harvested and snap frozen.Knee joints were ﬁxed in
neutral buffered formalin or Zamboni’s ﬁxative overnight and decalciﬁed
prior to being cut in coronal sections.Joints were then wax embedded
or frozen in OCT.Tissue sections were cut and stained with haematoxylin
and eosin to assess tissue architecture.Sensory nerves were immunolo-
calised using antibody to the neuropeptide calcitonin gene-related peptide
(CGRP).CD31 positive cells and PCNA immunoreactive CD31 positive cells
were detected to identify endothelial cells and proliferating endothelial
cells respectively in the synovia as two separate measures of the extent of
angiogenesis.Macrophage inﬁltration was identiﬁed by immunoreactivity
for the monoclonal antibody clone ED1.Computer-assisted image analysis
was used to quantify proliferating endothelial cell index and macrophage
fractional area.Pain behaviour [Incapacitance:difference in weight bearing
(g) between the hind paws (right-left)] and joint swelling (knee diameter)
were measured from before surgery until day 35.
Results: Meniscal injury increased pain behaviour in the operated an-
imals compared to naïve controls 12 days after surgery and this dif-
ference was maintained until day 35.Increased joint swelling,cartilage
damage,osteophytes and osteochondral angiogenesis were observed in
the MNX operated animals 35 days after surgery with increased syn-
ovial inﬂammation and angiogenesis compared to naïve controls.Sensory
nerves were located in the osteophytes,synovium and in the subchondral
bone,adjacent to blood vessels.Angiogenesis inhibitor PPI-2458 reduced
weight-bearing assymetry in the MNX model by day 19 compared to vehi-
cle treated animals [25g (95% CI,19 to 31), 46g (95% CI,37 to 55),P<0.01]
and maintained this reduction to day 35 [24g (95% CI,19 to 29), 47g
(95% CI,37 to 57),P<0.001].Pain behaviour however was not completely
abolished to naïve levels.Joint swelling was reduced with PPI-2458 to naïve
levels in the MNX model 14 days after surgery [0.2mm (95% CI,0.01 to 0.2),
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0.1mm (95% CI,0.02 to 0.1),P>0.05] and this reduction was maintained to
day 35,whereas at this point vehicle treated animals still had increased
joint swelling compared to PPI-2458 treated animals [0.4mm (95% CI,0.2 to
0.5),0.05mm (95% CI,-0.01 to 0.1),P<0.01].Synovial macrophage inﬁltration
was similarily reduced to naïve levels in PPI-2458 treated animals.PPI-2458
also reduced synovial angiogenesis at day 35 compared with vehicle treated
animals [1%(95% CI,0.8 to 1.2), 3%(95% CI,1 to 5),P<0.01],to levels similar to
naïve animals [0.6%(95% CI,0.4 to 0.9),P>0.05].
Conclusions: The angiogenesis inhibitor,PPI-2458 inhibited synovial angio-
genesis as well as pain behaviour in the meniscal injury (MNX) model of
OA.Angiogenesis may contribute to pain in OA by enhancing inﬂammation
and nerve growth.
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SYNOVIUM ANGIOGENESIS IN OSTEARTHRITIS: A NEW THERAPY TARGET
FOR CHONDROITIN SULFATE
M. Mathy-Hartert1, C. Lambert1, J.-E. Dubuc2, E. Montell3, J. Vergés3,
Y. Henrotin1
1Bone and Cartilage Res. Unit, Univ. of Liège, Liège, Belgium; 2Orthopaedic
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Purpose: Osteoarthritis (OA) is an important cause of pain and disability
in the ageing population. Angiogenesis and inﬂammation are closely inte-
grated process in OA and may contribute to its pathogenesis, as well as,
affect disease progression and pain. Chondroitin sulfate (CS) is a symp-
tomatic slow acting drug for OA and there is strong evidence suggesting
that CS may also be a structure disease modifying osteoarthritis drug. The
mechanisms underlying these effects remain poorly understood. This work
aimed to demonstrate the relation between inﬂammation and angiogenesis
of synovium and to study the effect of CS on synovium angiogenesis.
Methods: Synovial ﬁbroblast cells (SC) were isolated from OA synovial
specimen obtained from patients undergoing arthroscopy. At the surgery
time, the synovial membrane was dissected and primary SC cells coming
from either inﬂammatory (SCI) or non inﬂammatory (SCNI) area were
cultured separately for 7 days. Pro-angiogenic Vascular Endothelial Growth
Factor (VEGF) and anti-angiogenic thrombospondine (TSP)-1 were then
evaluated in the culture supernatant by speciﬁc sandwich enzyme-linked
immunoabsorbent assay (ELISA). To investigate the effects of Interleukin
(IL)-1beta and CS on pro- and anti- angiogenic factors expression, OA SC
were collected at passage 4. OA SC were then cultured for 5 or 24 h in the
absence or in the presence of IL-1beta (1 ng/ml) and with or without CS (10,
50, 200 μg/ml). Pro-angiogenic factors (VEGF, basic Fibroblast Growth Fac-
tor (bFGF), Nerve Growth Factor (NGF), Matrix Metalloproteinase (MMP)-2,
angiopoietin (ang)-1) and anti-angiogenic factors (TSP-1 and -2, Vascu-
lar Endothelial Growth Inhibitor (VEGI), ang-2 and Platelet Factor (PF)-4
gene expression was determined by real time RT-PCR. Nonparametric
Mann-Whitney test was used to analyze statistical difference.
Results: SCI cells produced more VEGF but less TSP-1 than SCNI cells.
IL-1beta, a pro-inﬂammatory cytokine, induced an imbalance between pro-
and anti-angiogenic factors. IL-1β signiﬁcantly stimulated mRNA expression
of pro-angiogenic factors and drastically inhibited anti-angiogenic factors.
In the basal or IL-1beta treated conditions, CS did not affect the expression
